Continuous Glucose Monitoring in Type 2 Diabetes Is Not Ready for Widespread Adoption
Rather than directly measuring blood glucose levels, continuous glucose monitoring devices track levels indirectly by measuring interstitial fluid glucose levels via a subcutaneous sensor attached to an external transmitter located on the upper arm or abdomen. Flash glucose monitoring devices (e.g.,...
Gespeichert in:
| Veröffentlicht in: | American family physician 2020-06, Vol.101 (10), p.646-646 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 646 |
|---|---|
| container_issue | 10 |
| container_start_page | 646 |
| container_title | American family physician |
| container_volume | 101 |
| creator | Robertson, Sandy L. Shaughnessy, Allen F. Slawson, David C. |
| description | Rather than directly measuring blood glucose levels, continuous glucose monitoring devices track levels indirectly by measuring interstitial fluid glucose levels via a subcutaneous sensor attached to an external transmitter located on the upper arm or abdomen. Flash glucose monitoring devices (e.g., Freestyle Libre) do not notify patients but transmit data when the receiver is in close proximity to the transmitter.1 Continuous glucose monitoring can alert patients with type 2 diabetes that they are becoming hypoglycemic, especially those using insulin who are at risk of severe hypoglycemia requiring urgent medical care. Most people with type 2 diabetes do not require self-monitoring of blood glucose, and unnecessary monitoring not only wastes money but can negatively impact quality of life.8 Until we have research supporting continuous glucose monitoring for patients with type 2 diabetes, especially those not receiving regular insulin injections, there are no patient-oriented benefits to justify its great expense and additional hassles for patients and physicians. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32463633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2454202434</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-3907088bd38ad30437b614bb81eed75e5cd1c7f0145dbcaa4d1afd87be7b293c3</originalsourceid><addsrcrecordid>eNqN0EFLwzAUB_AiipvTryABL4IU0iRt0uOoOgdTQTb0VpLmVTK2pDYpsm9vxtSDJ0-PP_x4vPc_SsZZTkmKixwfJ2OMMUkFFW-j5Mz7dYw8z8rTZEQJK2hB6ThZVc4GYwc3eDTbDI3zgB6dNcH1xr4jY9Fy1wEi6NZIBQE8mnv05AJ6Aal3qHU9ejUafNfHjKbadcE4e56ctHLj4eJ7TpLV_d2yekgXz7N5NV2kHaFlSGmJORZCaSqkpphRroqMKSUyAM1zyBudNbzFGcu1aqRkOpOtFlwBV6SkDZ0k14e9Xe8-BvCh3hrfwGYjLcSPasKwIDgTgkR69Yeu3dDbeF1UOSOYMMqiuvxWg9qCrrvebGW_q38Ki-DmAD5BudY3BmwDvyw2nFNexJ_wvvuoxf91ZYLcl1e5wQb6Bctoh70</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2454202434</pqid></control><display><type>article</type><title>Continuous Glucose Monitoring in Type 2 Diabetes Is Not Ready for Widespread Adoption</title><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Robertson, Sandy L. ; Shaughnessy, Allen F. ; Slawson, David C.</creator><creatorcontrib>Robertson, Sandy L. ; Shaughnessy, Allen F. ; Slawson, David C.</creatorcontrib><description>Rather than directly measuring blood glucose levels, continuous glucose monitoring devices track levels indirectly by measuring interstitial fluid glucose levels via a subcutaneous sensor attached to an external transmitter located on the upper arm or abdomen. Flash glucose monitoring devices (e.g., Freestyle Libre) do not notify patients but transmit data when the receiver is in close proximity to the transmitter.1 Continuous glucose monitoring can alert patients with type 2 diabetes that they are becoming hypoglycemic, especially those using insulin who are at risk of severe hypoglycemia requiring urgent medical care. Most people with type 2 diabetes do not require self-monitoring of blood glucose, and unnecessary monitoring not only wastes money but can negatively impact quality of life.8 Until we have research supporting continuous glucose monitoring for patients with type 2 diabetes, especially those not receiving regular insulin injections, there are no patient-oriented benefits to justify its great expense and additional hassles for patients and physicians.</description><identifier>ISSN: 0002-838X</identifier><identifier>EISSN: 1532-0650</identifier><identifier>PMID: 32463633</identifier><language>eng</language><publisher>KANSAS CITY: Amer Acad Family Physicians</publisher><subject>Diabetes ; General & Internal Medicine ; Glucose monitoring ; Hypoglycemia ; Insulin ; Life Sciences & Biomedicine ; Medicine, General & Internal ; Patients ; Primary Health Care ; Quality of life ; Science & Technology ; Sensors</subject><ispartof>American family physician, 2020-06, Vol.101 (10), p.646-646</ispartof><rights>Copyright American Academy of Family Physicians Jun 01, 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>5</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000537608800002</woscitedreferencesoriginalsourcerecordid><cites>FETCH-LOGICAL-p239t-3907088bd38ad30437b614bb81eed75e5cd1c7f0145dbcaa4d1afd87be7b293c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,28253</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32463633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robertson, Sandy L.</creatorcontrib><creatorcontrib>Shaughnessy, Allen F.</creatorcontrib><creatorcontrib>Slawson, David C.</creatorcontrib><title>Continuous Glucose Monitoring in Type 2 Diabetes Is Not Ready for Widespread Adoption</title><title>American family physician</title><addtitle>AM FAM PHYSICIAN</addtitle><addtitle>Am Fam Physician</addtitle><description>Rather than directly measuring blood glucose levels, continuous glucose monitoring devices track levels indirectly by measuring interstitial fluid glucose levels via a subcutaneous sensor attached to an external transmitter located on the upper arm or abdomen. Flash glucose monitoring devices (e.g., Freestyle Libre) do not notify patients but transmit data when the receiver is in close proximity to the transmitter.1 Continuous glucose monitoring can alert patients with type 2 diabetes that they are becoming hypoglycemic, especially those using insulin who are at risk of severe hypoglycemia requiring urgent medical care. Most people with type 2 diabetes do not require self-monitoring of blood glucose, and unnecessary monitoring not only wastes money but can negatively impact quality of life.8 Until we have research supporting continuous glucose monitoring for patients with type 2 diabetes, especially those not receiving regular insulin injections, there are no patient-oriented benefits to justify its great expense and additional hassles for patients and physicians.</description><subject>Diabetes</subject><subject>General & Internal Medicine</subject><subject>Glucose monitoring</subject><subject>Hypoglycemia</subject><subject>Insulin</subject><subject>Life Sciences & Biomedicine</subject><subject>Medicine, General & Internal</subject><subject>Patients</subject><subject>Primary Health Care</subject><subject>Quality of life</subject><subject>Science & Technology</subject><subject>Sensors</subject><issn>0002-838X</issn><issn>1532-0650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqN0EFLwzAUB_AiipvTryABL4IU0iRt0uOoOgdTQTb0VpLmVTK2pDYpsm9vxtSDJ0-PP_x4vPc_SsZZTkmKixwfJ2OMMUkFFW-j5Mz7dYw8z8rTZEQJK2hB6ThZVc4GYwc3eDTbDI3zgB6dNcH1xr4jY9Fy1wEi6NZIBQE8mnv05AJ6Aal3qHU9ejUafNfHjKbadcE4e56ctHLj4eJ7TpLV_d2yekgXz7N5NV2kHaFlSGmJORZCaSqkpphRroqMKSUyAM1zyBudNbzFGcu1aqRkOpOtFlwBV6SkDZ0k14e9Xe8-BvCh3hrfwGYjLcSPasKwIDgTgkR69Yeu3dDbeF1UOSOYMMqiuvxWg9qCrrvebGW_q38Ki-DmAD5BudY3BmwDvyw2nFNexJ_wvvuoxf91ZYLcl1e5wQb6Bctoh70</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Robertson, Sandy L.</creator><creator>Shaughnessy, Allen F.</creator><creator>Slawson, David C.</creator><general>Amer Acad Family Physicians</general><general>American Academy of Family Physicians</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20200601</creationdate><title>Continuous Glucose Monitoring in Type 2 Diabetes Is Not Ready for Widespread Adoption</title><author>Robertson, Sandy L. ; Shaughnessy, Allen F. ; Slawson, David C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-3907088bd38ad30437b614bb81eed75e5cd1c7f0145dbcaa4d1afd87be7b293c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Diabetes</topic><topic>General & Internal Medicine</topic><topic>Glucose monitoring</topic><topic>Hypoglycemia</topic><topic>Insulin</topic><topic>Life Sciences & Biomedicine</topic><topic>Medicine, General & Internal</topic><topic>Patients</topic><topic>Primary Health Care</topic><topic>Quality of life</topic><topic>Science & Technology</topic><topic>Sensors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robertson, Sandy L.</creatorcontrib><creatorcontrib>Shaughnessy, Allen F.</creatorcontrib><creatorcontrib>Slawson, David C.</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robertson, Sandy L.</au><au>Shaughnessy, Allen F.</au><au>Slawson, David C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Continuous Glucose Monitoring in Type 2 Diabetes Is Not Ready for Widespread Adoption</atitle><jtitle>American family physician</jtitle><stitle>AM FAM PHYSICIAN</stitle><addtitle>Am Fam Physician</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>101</volume><issue>10</issue><spage>646</spage><epage>646</epage><pages>646-646</pages><issn>0002-838X</issn><eissn>1532-0650</eissn><abstract>Rather than directly measuring blood glucose levels, continuous glucose monitoring devices track levels indirectly by measuring interstitial fluid glucose levels via a subcutaneous sensor attached to an external transmitter located on the upper arm or abdomen. Flash glucose monitoring devices (e.g., Freestyle Libre) do not notify patients but transmit data when the receiver is in close proximity to the transmitter.1 Continuous glucose monitoring can alert patients with type 2 diabetes that they are becoming hypoglycemic, especially those using insulin who are at risk of severe hypoglycemia requiring urgent medical care. Most people with type 2 diabetes do not require self-monitoring of blood glucose, and unnecessary monitoring not only wastes money but can negatively impact quality of life.8 Until we have research supporting continuous glucose monitoring for patients with type 2 diabetes, especially those not receiving regular insulin injections, there are no patient-oriented benefits to justify its great expense and additional hassles for patients and physicians.</abstract><cop>KANSAS CITY</cop><pub>Amer Acad Family Physicians</pub><pmid>32463633</pmid><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-838X |
| ispartof | American family physician, 2020-06, Vol.101 (10), p.646-646 |
| issn | 0002-838X 1532-0650 |
| language | eng |
| recordid | cdi_pubmed_primary_32463633 |
| source | Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals |
| subjects | Diabetes General & Internal Medicine Glucose monitoring Hypoglycemia Insulin Life Sciences & Biomedicine Medicine, General & Internal Patients Primary Health Care Quality of life Science & Technology Sensors |
| title | Continuous Glucose Monitoring in Type 2 Diabetes Is Not Ready for Widespread Adoption |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A21%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Continuous%20Glucose%20Monitoring%20in%20Type%202%20Diabetes%20Is%20Not%20Ready%20for%20Widespread%20Adoption&rft.jtitle=American%20family%20physician&rft.au=Robertson,%20Sandy%20L.&rft.date=2020-06-01&rft.volume=101&rft.issue=10&rft.spage=646&rft.epage=646&rft.pages=646-646&rft.issn=0002-838X&rft.eissn=1532-0650&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2454202434%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2454202434&rft_id=info:pmid/32463633&rfr_iscdi=true |